Skip Navigation


Rheumatology Advance Access originally published online on January 23, 2007
Rheumatology 2007 46(4):715-716; doi:10.1093/rheumatology/kel410
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/4/715    most recent
kel410v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Doe, S.
Right arrow Articles by Hamilton, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doe, S.
Right arrow Articles by Hamilton, J.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

Uptake of influenza vaccination in patients on immunosuppressant agents for rheumatological diseases: a follow-up audit of the influence of secondary care

S. Doe, S. Pathare, C. A. Kelly, C. R. Heycock, J. Binding and J. Hamilton

Department of Rheumatology, Queen Elizabeth Hospital, Gateshead, UK

Correspondence to: S. Pathare, E-mail: skp1110@hotmail.com

The first 10% of the full text of this article appears below.

SIR, patients with rheumatological diseases such as rheumatoid arthritis (RA) are at increased risk of infections and treatment with immunosuppressive agents may increase this risk [1]. Guidelines from the British Society for Rheumatology (BSR) state that patients with RA on immunosuppressant disease-modifying anti-rheumatic drugs (DMARDs) should receive annual Influenza immunization [2]. An overall target set by the Department of Health (DoH) in UK is 70% for the uptake of Influenza immunization in people aged 65 yrs [3]. An . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?